CA2900050A1 - Methods for producing diketopiperazines and compositions containing diketopiperazines - Google Patents

Methods for producing diketopiperazines and compositions containing diketopiperazines Download PDF

Info

Publication number
CA2900050A1
CA2900050A1 CA2900050A CA2900050A CA2900050A1 CA 2900050 A1 CA2900050 A1 CA 2900050A1 CA 2900050 A CA2900050 A CA 2900050A CA 2900050 A CA2900050 A CA 2900050A CA 2900050 A1 CA2900050 A1 CA 2900050A1
Authority
CA
Canada
Prior art keywords
albumin
dkp
stream
composition
hsa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2900050A
Other languages
English (en)
French (fr)
Inventor
David Bar-Or
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ampio Pharmaceuticals Inc
Original Assignee
Ampio Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ampio Pharmaceuticals Inc filed Critical Ampio Pharmaceuticals Inc
Publication of CA2900050A1 publication Critical patent/CA2900050A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biomedical Technology (AREA)
CA2900050A 2013-02-01 2014-02-03 Methods for producing diketopiperazines and compositions containing diketopiperazines Abandoned CA2900050A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361759922P 2013-02-01 2013-02-01
US61/759,922 2013-02-01
PCT/US2014/014478 WO2014121210A1 (en) 2013-02-01 2014-02-03 Methods for producing diketopiperazines and compositions containing diketopiperazines

Publications (1)

Publication Number Publication Date
CA2900050A1 true CA2900050A1 (en) 2014-08-07

Family

ID=51263032

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2900050A Abandoned CA2900050A1 (en) 2013-02-01 2014-02-03 Methods for producing diketopiperazines and compositions containing diketopiperazines

Country Status (15)

Country Link
US (1) US20150366932A1 (https=)
EP (1) EP2950811A4 (https=)
JP (1) JP6387019B2 (https=)
KR (1) KR20150114984A (https=)
CN (1) CN105188737A (https=)
AU (1) AU2014212095B2 (https=)
BR (1) BR112015017958A2 (https=)
CA (1) CA2900050A1 (https=)
EA (1) EA030414B1 (https=)
HK (1) HK1214772A1 (https=)
IL (1) IL240125A0 (https=)
MX (1) MX2015009908A (https=)
PH (1) PH12015501705A1 (https=)
SG (2) SG10201706213RA (https=)
WO (1) WO2014121210A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002011676A2 (en) 2000-08-04 2002-02-14 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
EP1622633B1 (en) 2003-05-15 2016-02-24 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
EP2300011A4 (en) 2008-05-27 2012-06-20 Dmi Life Sciences Inc THERAPEUTIC PROCESSES AND COMPOUNDS
EP3721884A1 (en) 2011-10-10 2020-10-14 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease with da-dkp (= aspartyl-alanyl diketopiperazine)
SG10201608087WA (en) 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
CN103841974A (zh) 2011-10-28 2014-06-04 安皮奥制药股份有限公司 鼻炎的治疗
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
CA2958080A1 (en) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
US11389512B2 (en) 2015-06-22 2022-07-19 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
US10426796B2 (en) * 2016-06-13 2019-10-01 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
US10456423B2 (en) 2016-06-13 2019-10-29 SMART SURGICAL, Inc. Compositions for biological systems and methods for preparing and using the same
WO2021016186A1 (en) * 2019-07-19 2021-01-28 University Of Utah Research Foundation Rapid sperm separation based on sperm morphology and motility
WO2021163693A1 (en) * 2020-02-16 2021-08-19 Pur Biologics, Inc. Methods of manufacturing extracellular matrix using aspartyl alanyl diketopiperazine (da-dkp)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092556A5 (https=) * 1970-04-02 1972-01-21 Snam Progetti
US5561115A (en) * 1994-08-10 1996-10-01 Bayer Corporation Low temperature albumin fractionation using sodium caprylate as a partitioning agent
US5811241A (en) * 1995-09-13 1998-09-22 Cortech, Inc. Method for preparing and identifying N-substitued 1,4-piperazines and N-substituted 1,4-piperazinediones
JP2000005569A (ja) * 1998-06-24 2000-01-11 Asahi Chem Ind Co Ltd 直列多段濾過法
WO2002011676A2 (en) * 2000-08-04 2002-02-14 Dmi Biosciences, Inc. Method of using diketopiperazines and composition containing them
EP1622633B1 (en) * 2003-05-15 2016-02-24 Ampio Pharmaceuticals, Inc. Treatment of t-cell mediated diseases
CN1791420A (zh) * 2003-05-15 2006-06-21 Dmi生物科学公司 T－细胞介导的疾病的治疗
US7790039B2 (en) * 2003-11-24 2010-09-07 Northwest Biotherapeutics, Inc. Tangential flow filtration devices and methods for stem cell enrichment
US20050197496A1 (en) * 2004-03-04 2005-09-08 Gtc Biotherapeutics, Inc. Methods of protein fractionation using high performance tangential flow filtration
MX2007002085A (es) * 2004-08-20 2007-07-19 Prometic Biosciences Ltd Esquemas de aislamiento y purificacion consecutivos de proteinas mediante cromatografia de afinidad.
CA2776241A1 (en) * 2009-10-30 2011-05-05 Novozymes Biopharma Dk A/S Albumin variants
WO2012174472A1 (en) * 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
EP3721884A1 (en) * 2011-10-10 2020-10-14 Ampio Pharmaceuticals, Inc. Treatment of degenerative joint disease with da-dkp (= aspartyl-alanyl diketopiperazine)
SG10201608087WA (en) * 2011-10-10 2016-11-29 Ampio Pharmaceuticals Inc Implantable medical devices with increased immune tolerance, and methods for making and implanting
CN103841974A (zh) * 2011-10-28 2014-06-04 安皮奥制药股份有限公司 鼻炎的治疗

Also Published As

Publication number Publication date
EP2950811A4 (en) 2016-06-08
JP6387019B2 (ja) 2018-09-05
PH12015501705A1 (en) 2015-10-12
BR112015017958A2 (pt) 2017-07-11
HK1214772A1 (zh) 2016-08-05
EA030414B1 (ru) 2018-08-31
AU2014212095B2 (en) 2018-07-26
MX2015009908A (es) 2015-09-24
EP2950811A1 (en) 2015-12-09
CN105188737A (zh) 2015-12-23
WO2014121210A1 (en) 2014-08-07
US20150366932A1 (en) 2015-12-24
EA201500783A1 (ru) 2016-05-31
AU2014212095A1 (en) 2015-09-10
SG11201505715RA (en) 2015-08-28
JP2016511238A (ja) 2016-04-14
KR20150114984A (ko) 2015-10-13
IL240125A0 (en) 2015-09-24
SG10201706213RA (en) 2017-09-28

Similar Documents

Publication Publication Date Title
US20150366932A1 (en) Methods for producing diketopiperazines and compositions containing diketopiperazines
US10428107B2 (en) Method for isolating and purifying recombinant human serum albumin from transgenic rice grain
CN103347530B (zh) 糖尿病的治疗或预防剂
CN1044121C (zh) 分离凝血因子viii配合物的方法
EP2537862A1 (en) A process of purifying coagulation factor VIII
RS57292B1 (sr) Ace2 polipeptid
FI4108259T3 (fi) Prosessi vasta-aineiden konsentroimiseksi ja niiden terapeuttisia tuotteita
CA2697404A1 (fr) Procede de purification du facteur viii et du facteur von willebrand
EA022821B1 (ru) Способ получения биологически активного рекомбинантного г-ксф человека
CN113144169A (zh) 一种黄嘌呤氧化酶抑制肽及其应用
IL293286A (en) vegf mini-traps and methods of using them
US20240025950A1 (en) Method of purification of recombinantly-produced rsv proteins in trimeric form
CN102321168B (zh) 新型血小板生成素拟肽复性和纯化方法
CA3190141A1 (en) Improvements to wash solutions for anion exchange chromatography in a method of purification of recombinantly-produced rsv proteins
CN104163850A (zh) 一种小分子抗体亲和肽及其应用
CN1313487C (zh) 具有抗菌作用的免疫活性肽（Trpi）
CN1563404A (zh) 米糠蛋白降血压肽(ace 抑制肽)的制备方法
CN105061558A (zh) 一种金枪鱼蒸煮液活性肽及其制备方法和糖尿病治疗用途
CN113072621B (zh) 一种牦牛骨降血压肽及其制备方法与应用
CN116120431A (zh) 一种抗氧化胶原多肽、制备方法及其应用
CN115161371A (zh) 一种牛乳酪蛋白水解制备寡肽的方法
KR20200038309A (ko) 폰 빌레브란트 인자의 바이러스 여과 방법
Merah PURIFICATION OF POTENT ANGIOTENSIN CONVERTING ENZYME (ACE)-INHIBITORY PEPTIDES DERIVED FROM RED TILAPIA (Oreochromis Sp.) BY-PRODUCTS
JPH0482898A (ja) 新規なペプチド及びアンジオテンシン変換酵素阻害剤
WO2026006884A1 (en) Modulators of fxii-upar

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20200204